1Shimizu M Saitoh Y, Itoh H, et al. lmmunohistochemieal staining of H-ras oncogene product in normal, benign and malignant human pancreatic tissue[J]. Hum Pathol, 1990,21 (6):607-612.
3Kapitanovi S, Berkovi M, Radosevic S, et al. nm23-hl expression and loss of heterozygosity in colon adenocarcinoma[J]. J Clin Pathol, 2004,57(12):1312-1318.
4Nesi G, Palli D, Pernice LM, et al. Expression of nm23 gene in gastric Cancer is associated with a poor 5-year survival [J]. Anti-Cancer Res, 2001,21 (5):3643-3649.
2Fukunaga M,Monden T,Nakanishi H,et al.Immunohistochemical study of p53 in gastric carcinoma[J].Am J Clin Pathol,1994,101 (2):177 ～180.
3Kodera Y,Isobe K,Yamauchi M,et al.Expression of nm23 H-1 RNA levels in human gastric cancer tissues.A negative correlation with nodal metastasis[J].Cancer,1994,73(2):259～265.
4Nakayama H,Yasui W,Yokozaki H,et al.Reduced expression of nm23 is associated with metastasis of human gastric carcinomas[J].Jpn J Cancer Res,1993,84(2):184 ～ 190.
5Bartek J,Bartkova J,Vojtesek B,et al.Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies[J]Oncogene,1991,6(9):1699 ～ 1703.
6Joypaul BV,Hopwood D,Newman EL,et al.The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma[J].Br J Cancer,1994,69(5):943 ～946.
7Martin HM,Filipe MI,Morris RW,et al.p53 expression and prognosis in gastric carcinoma[J].Int J Cancer,1992,50(6):859 ～ 862.
8Kakeji Y,Korenaga D,Tsujitani S,et al.Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes[J].Br J Cancer,1993,67(3):589 ～ 593.
9Pinto-de-Sousa J,Silva F,David L,et al.Clinicopathological significance and survival influence of p53 protein expression in gastric carcinoma[J].Histopathology,2004,44(4):323 ～ 331.
10Hennessy C,Henry JA,May FE,et al.Expression of the antimetastatic gene nm23 in human breast cancer:an association with good prognosis[J].J Natl Cancer Inst,1991,83(4):281 ～ 285.
